首页> 美国卫生研究院文献>OncoTargets and therapy >A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer

【2h】

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer

机译：PD-1 / PD-L1免疫检查点抑制剂作为治疗转移性膀胱癌的疗效和安全性的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThis article is a meta-analysis aiming to systematically assess the efficacy and safety profiles of PD-1/PD-L1 inhibitors in patients with advanced or metastatic bladder cancer.

机译：背景本文是一项荟萃分析，旨在系统评估PD-1 / PD-L1抑制剂对晚期或转移性膀胱癌患者的疗效和安全性。

著录项

期刊名称 OncoTargets and therapy
作者
Zhongyuan Fan; Ye Liang; Xuecheng Yang; Bin Li; Lili Cui; Lei Luo; Yuefeng Jia; Yonghua Wang; Haitao Niu;
展开▼
作者单位

展开▼
年(卷),期 2019(12),-1
年度 2019
页码 1791–1801
总页数 11
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
PD-1 inhibitor PD-L1 inhibitor immunotherapy metastatic bladder cancer meta-analysis bladder cancer oncology;

机译：PD-1抑制剂;PD-L1抑制剂;免疫疗法;转移性膀胱癌;荟萃分析;膀胱癌;肿瘤科;

相似文献

外文文献
中文文献
专利

1. A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer [J] . Zhongyuan Fan, Ye Liang, Xuecheng Yang, OncoTargets and therapy . 2019,第1期

机译：PD-1 / PD-L1免疫检查点抑制剂作为转移性膀胱癌治疗的疗效和安全性的荟萃分析
2. Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis [J] . International immunopharmacology . 2020,第期

机译：PD-L1表达对非小细胞肺癌治疗PD-L1表达的预测效果（PD-1 / PD-L1抑制剂）治疗非小细胞肺癌：META分析
3. Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: A meta-analysis [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：PD-L1表达对非小细胞肺癌治疗PD-L1表达的预测效果（PD-1 / PD-L1抑制剂）治疗非小细胞肺癌：META分析
4. Multiparametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues [C] . Shawn P. Fahl International Molecular Medicine Tri-Conference. . 2019

机译：离聚肿瘤和正常组织中检查点抑制剂（PD-1和PD-L1）的多次流式细胞术分析
5. Immune Checkpoints PD-1/PD-L1 and Natural Killer Cells in Chemo-resistant Colorectal Cancer [D] . Siu, Hon Lam Elaine. 2019

机译：免疫检查点PD-1 / PD-L1和化疗结直肠癌中的天然杀伤细胞
6. Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer—A Systematic Review and Network Meta-Analysis [O] . Koichi Ando, Ryo Manabe, Yasunari Kishino, 2021

机译：抗PD-1 / PD-L1免疫检查点抑制剂对难治性或复发先进的非小细胞肺癌的比较疗效和安全性 - 一种系统综述和网络元分析
7. >A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer [O] . Zhongyuan Fan, Ye Liang, Xuecheng Yang, 2019

机译：pd-1 / pd-l1免疫检查点抑制剂作为转移性膀胱癌的处理的疗效和安全性的荟萃分析

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer

摘要

著录项

相似文献

相关主题

期刊订阅